Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.39 USD | +2.57% | +0.48% | -54.16% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.16% | 523M | |
+33.57% | 49.46B | |
+1.74% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.74% | 26.61B | |
-22.16% | 18.64B | |
+7.82% | 13.16B | |
+29.52% | 12.55B | |
+24.11% | 12.1B |
- Stock Market
- Equities
- VERV Stock
- News Verve Therapeutics, Inc.
- Credit Suisse Lowers Verve Therapeutics' Price Target to $32 From $37, Maintains Neutral Rating